Biogen Non-Current Portion of LTD and Capital Lease Obligation (Annual) Analysis

Biogen, Inc. (BIIB)

171.56 -2.24 (-1.29%) USD | NASDAQ | Jan 23, 16:00

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) for BIIB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
AbbVie, Inc.	Upgrade
Stoke Therapeutics, Inc.	--
Alnylam Pharmaceuticals, Inc.	Upgrade
Insmed, Inc.	Upgrade